Pathology 2020
DOI: 10.1016/b978-0-12-815972-9.00003-2
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative stress and diabetic retinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 75 publications
0
3
0
Order By: Relevance
“…It is generally accepted that oxidative stress has a fundamental role in vascular dysfunction [86]. In diabetic retinopathy, oxidative stress-induced decreased nitric oxide bioavailability contributes to endothelial cell dysfunction, basement membrane thickening, and pericyte apoptosis, resulting in altered microvasculature [87]. Lipid peroxidation is one of the major mechanisms of oxidative damage [88].…”
Section: The Landscape Of Rosmentioning
confidence: 99%
“…It is generally accepted that oxidative stress has a fundamental role in vascular dysfunction [86]. In diabetic retinopathy, oxidative stress-induced decreased nitric oxide bioavailability contributes to endothelial cell dysfunction, basement membrane thickening, and pericyte apoptosis, resulting in altered microvasculature [87]. Lipid peroxidation is one of the major mechanisms of oxidative damage [88].…”
Section: The Landscape Of Rosmentioning
confidence: 99%
“…It has been widely accepted that oxidative stress caused by the imbalance of generation and detoxification of free radicals can lead to aging [ 28 ], and diverse diseases such as diabetic retinopathy [ 29 ], Alzheimer’s disease and Parkinson’s disease [ 30 ]. Therefore, finding more effective antioxidants against oxidative stress damage is essential [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Intraoperative application of mitomycin C to sclera bed is another strategy which has gained increasing acceptance but entail several complications. [19][20] The recurrence rate after amniotic membrane transplantation was initially reported to be 10.9% for primary and 37.5% for secondary pterygium, being much higher than recurrent rates of conjunctival auto grafts, 23 reducing to 3% and 9.5% respectively, after modifying the surgical technique, 24 which compared favorably with conjunctival auto grafts 14 being superior to that of bare sclera technique 25 that we have followed in our study as Fallah et al 26 performed for treatment of recurrent pterygia. Matin et al showed that amniotic membrane graft alone is effective adjunctive treatment for recurrence pterygia and the addition of intra operative mitomycin c did not further reduce recurrence rates.…”
Section: Occupationmentioning
confidence: 99%